4.7 Editorial Material

Immunotherapy in Patients With Locally Advanced Esophageal Carcinoma: ASCO Treatment of Locally Advanced Esophageal Carcinoma Guideline Rapid Recommendation Update

Journal

JOURNAL OF CLINICAL ONCOLOGY
Volume 39, Issue 28, Pages 3182-+

Publisher

LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1200/JCO.21.01831

Keywords

-

Categories

Funding

  1. Merck
  2. Oncolys BioPharma
  3. Bristol Myers Squibb

Ask authors/readers for more resources

The ASCO Rapid Recommendations Updates aim to disseminate updated recommendations in a timely manner to provide better information on cancer care.
ASCO Rapid Recommendations Updates highlight revisions to select ASCO guideline recommendations as a response to the emergence of new and practice-changing data. The rapid updates are supported by an evidence review and follow the guideline development processes outlined in the ASCO Guideline Methodology Manual. The goal of these articles is to disseminate updated recommendations, in a timely manner, to better inform health practitioners and the public on the best available cancer care options.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available